A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)

Clinical trial NCT02596971 · COMPLETED

Trial details

NCT number: NCT02596971
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma, Lymphoma Follicular

Start date: 2015-12-22
Primary completion: 2018-04-11
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.